Mixed beta3-adrenoceptor agonist and alpha1-adrenoceptor antagonist properties of nebivolol in rat thoracic aorta.
about
New advances in beta-blocker therapy in heart failureRationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data.Ligand-directed signalling at beta-adrenoceptorsClinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failureHypoglycemia, polycythemia and hyponatremia in a newborn exposed to nebivolol during pregnancy.Mirabegron relaxes urethral smooth muscle by a dual mechanism involving β3 -adrenoceptor activation and α1 -adrenoceptor blockadeInvestigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aortaβ1-Adrenergic receptor blockade extends the life span of Drosophila and long-lived mice.Genetics and pathophysiology of arterial stiffness.Nitric oxide mechanisms of nebivolol.Vasodilatory mechanisms of beta receptor blockade.β3 -AR and the vertebrate heart: a comparative view.Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation.Immunological and pleiotropic effects of individual β-blockers and their relevance in cancer therapies.β3-adrenoceptor impacts apoptosis in cultured cardiomyocytes via activation of PI3K/Akt and p38MAPK.Celiprolol induces β(3)-adrenoceptors-dependent relaxation in isolated porcine coronary arteries.
P2860
Q26865919-98A5F637-9149-48C5-85FA-0FEE38A37FFCQ30491698-61D46342-D8EF-4B1C-9F8D-23563202E828Q33730592-01BE9A6C-28E8-4D04-8F76-E1C0D404C60DQ34386568-50D16D7E-C4EA-41D0-B2AB-E3964B8FE4A6Q35056331-18D25EA8-DB4C-45E2-B745-CC1815C42A64Q36506889-9F0F12EE-E4D9-4C4B-9055-0DA51AC8E208Q37230717-5453284D-D8EF-4553-BB74-4BEF7953753AQ37300549-B5B567DF-5244-4DF3-BD5B-72095C6C9BB0Q37355473-5DA0D973-B286-4B4D-80E2-BB55884EF2A1Q37483065-8293A47E-77AE-47FA-AB91-572CE302BE3CQ38013691-8AFD266F-5C6C-466C-9D00-3F4D3B4BCAD4Q38391176-507E8393-7149-4A7C-8D42-509E5EDBF8FAQ43690830-4A02D03D-5FD3-48AC-B042-D74459E65EF5Q44375078-79AD52F7-BCB1-4706-85BF-4E98FEA50522Q51460033-3F00BD0F-C6E9-47FC-8D20-050E92343125Q54217454-6190083E-16B3-4993-9796-055166D691DBQ54238661-294C4AEF-14E3-4500-B735-18A132B2B55A
P2860
Mixed beta3-adrenoceptor agonist and alpha1-adrenoceptor antagonist properties of nebivolol in rat thoracic aorta.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Mixed beta3-adrenoceptor agoni ...... bivolol in rat thoracic aorta.
@en
Mixed beta3-adrenoceptor agoni ...... bivolol in rat thoracic aorta.
@nl
type
label
Mixed beta3-adrenoceptor agoni ...... bivolol in rat thoracic aorta.
@en
Mixed beta3-adrenoceptor agoni ...... bivolol in rat thoracic aorta.
@nl
prefLabel
Mixed beta3-adrenoceptor agoni ...... bivolol in rat thoracic aorta.
@en
Mixed beta3-adrenoceptor agoni ...... bivolol in rat thoracic aorta.
@nl
P2093
P2860
P356
P1476
Mixed beta3-adrenoceptor agoni ...... bivolol in rat thoracic aorta.
@en
P2093
Bertrand Rozec
Chantal Gauthier
Jacques Noireaud
Thuy Tran Quang
P2860
P304
P356
10.1038/SJ.BJP.0706648
P407
P577
2006-04-01T00:00:00Z